SUFENTANIL CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Sufentanil Citrate patents expire, and when can generic versions of Sufentanil Citrate launch?
Sufentanil Citrate is a drug marketed by Hikma, Hospira, and Watson Labs. and is included in three NDAs.
The generic ingredient in SUFENTANIL CITRATE is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sufentanil Citrate
A generic version of SUFENTANIL CITRATE was approved as sufentanil citrate by HIKMA on December 15th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUFENTANIL CITRATE?
- What are the global sales for SUFENTANIL CITRATE?
- What is Average Wholesale Price for SUFENTANIL CITRATE?
Summary for SUFENTANIL CITRATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 7 |
| Patent Applications: | 721 |
| What excipients (inactive ingredients) are in SUFENTANIL CITRATE? | SUFENTANIL CITRATE excipients list |
| DailyMed Link: | SUFENTANIL CITRATE at DailyMed |
Recent Clinical Trials for SUFENTANIL CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brugmann University Hospital | Phase 3 |
| Jiangang Song | N/A |
| West China Hospital | Phase 4 |
Pharmacology for SUFENTANIL CITRATE
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for SUFENTANIL CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for SUFENTANIL CITRATE
US Patents and Regulatory Information for SUFENTANIL CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074413-001 | Dec 15, 1995 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074534-001 | Dec 11, 1996 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | SUFENTANIL CITRATE | sufentanil citrate | INJECTABLE;INJECTION | 074406-001 | Dec 15, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
